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survival in vitamin E-incorporated polyethylene
cups in reversed hybrid total hip arthroplasty:
design of a randomized controlled trial
Hugo C van der Veen1*, Inge van den Akker-Scheek2, Sjoerd K Bulstra2 and Jos JAM van Raay1Abstract
Background: Aseptic loosening of total hip arthroplasties is generally caused by periprosthetic bone resorption due
to tissue reactions on polyethylene wear particles. In vitro testing of polyethylene cups incorporated with vitamin E
shows increased wear resistance. The objective of this study is to compare vitamin E-stabilized highly cross-linked
polyethylene with conventional cross-linked polyethylene in “reversed hybrid” total hip arthroplasties (cemented
all-polyethylene cups combined with uncemented femoral stems). We hypothesize that the adjunction of vitamin E
leads to a decrease in polyethylene wear in the long-term. We also expect changes in bone mineral density, less
osteolysis, equal functional scores and increased implant survival in polyethylene cemented cups incorporated with
vitamin E in the long-term.
Design: A double-blinded randomized controlled trial will be conducted. Patients to be included are aged under
70, suffer from non-inflammatory degenerative joint disease of the hip and are scheduled for a primary total hip
arthroplasty. The study group will receive a reversed hybrid total hip arthroplasty with a vitamin E-stabilized highly
cross-linked polyethylene cemented cup. The control group will receive a reversed hybrid total hip arthroplasty with
a conventional cross-linked polyethylene cemented cup. Radiological follow-up will be assessed at 6 weeks and at
1, 3, 5, 7 and 10 years postoperatively, to determine polyethylene wear and osteolysis. Patient-reported functional
status (HOOS), physician-reported functional status (Harris Hip Score) and patients’ physical activity behavior
(SQUASH) will also be assessed at these intervals. Acetabular bone mineral density will be assessed by dual energy
X-ray absorptiometry (DEXA) at 6 weeks and at 1 year and 2 years postoperatively. Implant survival will be
determined at 10 years postoperatively.
Discussion: In vitro results of vitamin E-stabilized polyethylene are promising, showing increased wear resistance.
However, controlled clinical follow-up data are not available at this moment.
This randomized controlled trial has been designed to determine wear, bone mineral density, functional outcome
and survival in reversed hybrid total hip arthroplasty comparing cemented vitamin E-stabilized highly cross-linked
polyethylene cups with cemented conventional cross-linked polyethylene cups.
Trial registration: Dutch Trial Registry NTR3049* Correspondence: hcvanderveen@hotmail.com
1Department of Orthopaedic Surgery, Martini Hospital, P.O. Box 30033,
9700 RM Groningen, The Netherlands
Full list of author information is available at the end of the article
© 2012 van der Veen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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The most important factor for late implant failure in
total hip arthroplasty is aseptic mechanical loosening of
one or both components. The Nordic arthroplasty regis-
tries (Sweden, Norway and Denmark) show aseptic loosen-
ing as the main reason for revision in total hip arthroplasty
(34.8-50.4%), followed by dislocation (23.4-33.5%) and
infection (15.0-15.8%) [1]. Periprosthetic bone resorption,
due to a cellular- and molecular-mediated foreign body re-
action to polyethylene wear particles, is one of the main
causes for this loosening [2,3].
In the 1950s and 1960s, total hip arthroplasty was per-
formed using a metal-on-metal articulation [4,5]. In the
1970s, due to the success of Charnley’s low friction arthro-
plasty [6], metal-on-polyethylene articulations were increas-
ingly applied. As polyethylene wear particles turned out to
promote aseptic loosening, newer polyethylenes were devel-
oped to reduce wear. In the 1990s first-generation cross-
linked ultra high molecular weight polyethylenes were
introduced. This development led to a reduction in poly-
ethylene wear. In looking for alternative bearing couples
lacking the issue of polyethylene wear, the use of hard-on-
hard bearings like metal-on-metal and ceramic-on-ceramic
increased, especially in young active patients [7].
Hard-on-hard bearings also have shown disadvantages
though. Although rare, ceramic articulations might lead
to fracture of the ceramic bearing and produce squeak-
ing noises [8]. Concerns remain over metal-on-metal
articulations because of the metal ion release and sub-
sequent elevated serum metal ion concentration [9].
Moreover, unpredictable local tissue reaction on metal
particles can result in pseudo-tumor formation around
the hip joint and perivascular lymphocytic infiltration
because of a delayed-type hypersensitivity reaction (asep-
tic lymphocytic vasculitis associated lesion, ALVAL) [10].
A metal-on-polyethylene articulation seems therefore
to be advocated above metal–on-metal articulation in
total hip arthroplasty [11].
Wear characteristics of ultra-high molecular-weight
polyethylene have been improved by the cross-linking
technique [12,13]. A disadvantage is the increased oxida-
tion and decreased fatigue strength of the polyethylene
due to the irradiation, remelting and annealing process
used in this technique. To prevent oxidation and
increase mechanical strength, second-generation highly
cross-linked polyethylene has been developed by incorp-
orating vitamin E [14,15]. In vitro testing of these
vitamin-E stabilized polyethylene cups shows good wear
properties and improved mechanical and fatigue pro-
perties [16]. The influence of vitamin E-stabilized poly-
ethylene cups on acetabular bone mineral density (BMD)
is unknown. Hypothetically, this modified polyethylene
leads to changes in acetabular bone mineral density due
to its different mechanical properties.The objective of this study is to compare vitamin
E-stabilized highly cross-linked polyethylene with con-
ventional cross-linked polyethylene in “reversed hybrid”
total hip arthroplasties (cemented all-polyethylene cups
combined with uncemented femoral stems). We hypo-
thesize that the adjunction of vitamin E to polyethylene
leads to a decrease in polyethylene wear in the long-term
(primary outcome parameter). We also expect changes
in BMD, less osteolysis, equal functional scores and
increased implant survival in polyethylene incorporated
with vitamin E (secondary outcome parameters) in the




A randomized controlled trial will be conducted.
Patients are randomized into one of the two treat-
ment groups using concealed envelopes. Cluster ran-
domization (per 10 patients) will be applied and the
random allocator sequence will be computer-generated
by an independent planner. Envelopes are opened one
week before surgery. Patients are blinded for treatment.
Only the surgeon and the primary investigator are aware
of the allocation type. Follow-up is therefore done by an
independent investigator, who is blinded for the treat-
ment allocation. The study design, procedures and
informed consent are approved by the local Medical
Ethical Committee (registration number 2011-29). The
trial is registered in the Netherlands Trial Registry
(NTR3049). Guidelines of the Consort Statement are
followed [17].
Study population
The study will be conducted at the Department of
Orthopaedic Surgery of the Martini Hospital, Groningen,
the Netherlands. Patients to be included suffer from
non-inflammatory degenerative joint disease of the hip
and are scheduled for a primary unilateral total hip
arthroplasty, and are aged under 70 years. Exclusion cri-
teria are secondary osteoarthritis of the hip, (active) arth-
ritis (e.g. rheumatic disease), peripheral neuropathy,
history of CVA or cognitive impairment (e.g. dementia).
Participation in the study is voluntary and informed con-
sent is required. The inclusion period is planned from
January 2012 to January 2014.
Intervention
Both investigated groups will receive a reversed hybrid total
hip arthroplasty. Gentamycine cement (Palacos®R + G,
Heraeus) will be used for cup fixation, applying third-
generation cementing techniques including vacuum
mixing, pulsed lavage and pressurization. The same
cementless 28-mm femoral component is used in both
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ium alloy (Ti6Al4V) stem (Mallory-Head®, Biomet) with a
cobalt-chromium-molybdenum 28 mm femoral head.
One group will receive a cemented vitamin E-stabilized
highly cross-linked polyethylene acetabular component
(E1™ Muller cup, Exceed ABT Cemented Cup System,
Biomet). The other group will receive a cemented con-
ventional cross-linked polyethylene acetabular compo-
nent without the adjunction of vitamin E (ArCom™
Muller cup, Exceed ABT Cemented Cup System,
Biomet).
A posterolateral surgical approach in lateral decubitus
position is used. Antibiotic prophylaxis with first-
generation cephalosporin will be given preoperatively
and during the first 24 hours intravenously.Follow-up
In this study the main outcome parameter is polyethyl-
ene wear (mm/y) 10 years postoperatively. Secondary
outcome parameters are periacetabular bone mineral
density, periprosthetic osteolysis, patient- and physician-
reported outcome and implant survival (Table 1).
Depending on the outcome parameters, measurements
will take place preoperatively, 6 weeks, and 1, 3, 5, 7 and
10 years postoperatively.Wear and osteolysis assessment
Wear will be determined on the routinely made conven-
tional AP radiographs. Standard supine anteroposterior
(AP) pelvic hip radiographs (with 115% magnification)
will be taken. The X-rays at 6 weeks will serve as base-
line, and will be compared 1, 3, 5, 7 and 10 years post-
operatively. Wear will be assessed using the 2D
measurement method as described by The et al. [18].
This method has been clinical validated by RSA and cor-
rects for projection differences of the acetabular
component. It has the advantage of approximating 3D-
wear measurements without the need of lateral radio-
graphs. Periacetabular and femoral radiolucencies will beTable 1 Secondary outcome parameters
1. polyethylene wear at 1, 3, 5 and 7 years postoperatively
2. relative decrease/increase in acetabular bone mineral
density (BMD) at 1 and 2 years postoperatively
3. acetabular and proximal femoral osteolytic changes at 1,
3, 5, 7 and 10 years postoperatively
4. patient-reported functional outcome (HOOS and SQUASH)
at 6 weeks and at 1, 3, 5, 7 and 10 years postoperatively
5. physician-reported functional outcome (Harris Hip Score)
at 6 weeks and at 1, 3, 5 and 10 years postoperatively
6. survival (number of revisions) determined at 5 and
10 years postoperatively
Other study parameters: gender, age, BMI, severity of arthrosis, complications,
size and inclination of the cup, surgical time and intraoperative blood loss.assessed according to the three zones of De Lee and
Charnley [19] and the femoral zones (especially zone 7) of
Gruen et al. [20]. The scoring will be undertaken by an in-
dependent reviewer.
Bone densitometry
BMD measurements will be performed using a dual
energy X-ray absorptiometry (DEXA) scanner (Hologic
Inc., Bedford, Mass., USA) in order to calculate BMD
changes in the pelvis as suggested by Wilkinson [21].
The contralateral normal hip will be scanned following a
standard manufacturer's protocol to establish BMD in
the femoral neck, trochanter, intertrochanteric, total hip
and Ward's triangle sites.
Functional outcome
The Hip disability and Osteoarthritis Outcome Score
(HOOS) will be used to assess patient-reported functional
status, health-related quality of life and physical activity
[22,23]. The short questionnaire to assess health-enhancing
physical activity (SQUASH) will be used to determine ha-
bitual physical activity behavior [24]. Dutch versions of the
HOOS and SQUASH will be used, as they are reliable and
validated questionnaires for the Dutch THA population
[25,26]. The Harris Hip Score will be used to assess
physician-reported functional status, including range of
motion [27,28].
Sample size
It is our hypothesis that reversed hybrid total hip arthro-
plasties with vitamin E-stabilized polyethylene will show
less polyethylene wear at 10 years compared to reversed
hybrid total hip arthroplasty without the adjunction of
vitamin E. In order to detect at least a clinically relevant
difference in wear of 0.5 mm with a standard deviation
of 0.07 mm, 63 patients are needed in each group (alpha
0.05, power 0.80). Based on previous studies we expect
a drop-out rate of 15%. We therefore aim to include
75 patients in each group, thus 150 patients in total.
Statistical analysis
Descriptive statistics
Descriptive statistics (means and standard deviations)
will be used to describe the patient characteristics and
outcome variables at the measurement points.
Univariate analysis
Student’s T-test will be used to determine if there is a
difference in wear at 10 years postoperatively between
the two groups. Differences in other outcome measures
(osteolytic changes, bone mineral density, HOOS, Harris
Hip score, SQUASH) between the two groups will also
be analyzed with a student’s T-test (or non-parametric
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measurement points.Multivariate analysis
A GEE (Generalized Estimating Equation) analysis will
be used to determine whether there is a difference on the
primary and secondary outcome variables between the
two groups over time, adjusted for relevant covariates. A
p-value of < 0.05 is considered statistically significant.Discussion
As previously mentioned, in vitro results of vitamin
E-incorporated polyethylene cups are promising, show-
ing increased wear resistance and improved mechanical
and fatigue properties. However, as yet no randomized
controlled clinical data have been published on the mid-
and long-term outcome of these modified polyethylene
cups. This study primarily focuses on the outcome of wear
in the long-term (10 years), comparing vitamin
E-incorporated polyethylene with conventional polyethyl-
ene in reversed hybrid total hip arthroplasties. Short- and
mid-term data will also be investigated in terms of peria-
cetabular bone density and functional outcome.
To our knowledge, there are no randomized controlled
trials that evaluate the incorporation of vitamin E in
cemented polyethylene cups versus cemented polyethyl-
ene cups without the adjunction of vitamin E in total hip
arthroplasty.Conclusion
This randomized controlled trial has been designed to
determine wear, bone mineral density, functional out-
come and survival in reversed hybrid total hip arthro-
plasty with vitamin E-stabilized highly cross-linked
polyethylene versus reversed hybrid total hip arthroplasty
with conventional cross-linked polyethylene.
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